George Yancopoulos

George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals.

Yancopoulos is a member of the National Academy of Sciences, and the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'George Yancopoulos', query time: 0.02s Refine Results
  1. 1
    428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)
    Article
Search Tools: Get RSS Feed — Email this Search